{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:10:08Z","timestamp":1788948608034,"version":"build-2803163510"},"reference-count":172,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccines that elicit durable immune responses require efficient delivery of antigen to antigen-presenting cells (APCs), in combination with appropriate contextual signals that promote immunity. Recombinant antibody vaccines are a flexible platform for antigen delivery in which monoclonal antibodies (mAbs) or antibody-derived fragments carry antigenic cargo to chosen receptors on target cells. In this review, we examine the design principles, mechanisms, and applications of recombinant antibody vaccines, with a focus on strategies targeting dendritic cells (DCs). DCs can take up, process, and present antigen, leading to effective induction of adaptive immune responses. Targeting of DCs with recombinant antibody vaccines improves the efficiency of antigen delivery and allows finetuning of responses through choice of a targeting receptor, antigen, and adjuvant. Recombinant antibody vaccines have been evaluated across a variety of immunological settings, including for vaccination against viral, bacterial, and protozoan pathogens, therapeutic cancer vaccination, and inverse vaccination to promote antigen-specific tolerance in models of autoimmune disease. Collectively, these studies demonstrate the versatile applications of recombinant antibody vaccines, although continued work is needed to define the elements most likely to support translation to the clinic. Overall, recombinant antibody vaccines provide a modular platform for targeted antigen delivery and represent a promising strategy for design of next-generation vaccines.<\/jats:p>","DOI":"10.3390\/vaccines14090788","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:24:02Z","timestamp":1788945842000},"page":"788","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant Antibody Vaccines for Targeted Antigen Delivery: Design Principles and Immunological Applications"],"prefix":"10.3390","volume":"14","author":[{"given":"Kaitlyn M.","family":"Pirogovsky","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, School of Medicine, Saint Louis University, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9663-1517","authenticated-orcid":false,"given":"Daniel","family":"Hawiger","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, School of Medicine, Saint Louis University, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gupta, M., Wahi, A., Sharma, P., Nagpal, R., Raina, N., Kaurav, M., Bhattacharya, J., Rodrigues Oliveira, S.M., Dolma, K.G., and Paul, A.K. (2022). Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines, 10.","DOI":"10.3390\/vaccines10122011"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zouali, M. (2025). Inverse Vaccination for Autoimmune Diseases: Insights into the Role of B Lymphocytes. Cells, 14.","DOI":"10.3390\/cells14141085"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S1359-6446(05)03600-7","article-title":"The rational design of vaccines","volume":"10","author":"Bramwell","year":"2005","journal-title":"Drug Discov. Today"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ghattas, M., Dwivedi, G., Lavertu, M., and Alameh, M.-G. (2021). Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines, 9.","DOI":"10.3390\/vaccines9121490"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nunnally, B.K., Turula, V.E., and Sitrin, R.D. (2015). Inactivated Viral Vaccines. Vaccine Analysis: Strategies, Principles, and Control, Springer.","DOI":"10.1007\/978-3-662-45024-6"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kashyap, D., Panda, M., Baral, B., Varshney, N., R, S., Bhandari, V., Parmar, H.S., Prasad, A., and Jha, H.C. (2022). Outer Membrane Vesicles: An Emerging Vaccine Platform. Vaccines, 10.","DOI":"10.3390\/vaccines10101578"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bourque, J., and Hawiger, D. (2022). Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo. Antibodies, 11.","DOI":"10.3390\/antib11010008"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"232ra51","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.7150\/thno.122332","article-title":"Development of a dendritic cell-targeted vaccine strategy using proximity-induced conjugation","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ymthe.2024.05.003","article-title":"Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice","volume":"32","author":"Cheang","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0105-2896.2004.00144.x","article-title":"Modulating vaccine responses with dendritic cells and Toll-like receptors","volume":"199","author":"Pulendran","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: Location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2019.05.037","article-title":"Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies","volume":"73","author":"Iberg","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Iberg, C.A., and Hawiger, D. (2020). Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases. Antibodies, 9.","DOI":"10.3390\/antib9020023"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lehmann, C.H., Heger, L., Heidkamp, G.F., Baranska, A., Luhr, J.J., Hoffmann, A., and Dudziak, D. (2016). Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies. Vaccines, 4.","DOI":"10.3390\/vaccines4020008"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41423-024-01167-5","article-title":"The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond","volume":"21","author":"Ngo","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41590-023-01454-9","article-title":"Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells","volume":"24","author":"Valente","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic Cells Revisited","volume":"39","author":"Cardoso","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-12-417028-5.00009-0","article-title":"Transcriptional control of dendritic cell development","volume":"120","author":"Murphy","year":"2013","journal-title":"Adv. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2402701","DOI":"10.1080\/19420862.2024.2402701","article-title":"Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors","volume":"16","author":"Hale","year":"2024","journal-title":"mAbs"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chiu, M.L., Goulet, D.R., Teplyakov, A., and Gilliland, G.L. (2019). Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies, 8.","DOI":"10.3390\/antib8040055"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: The neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Abdeldaim, D.T., and Schindowski, K. (2023). Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15102402"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-020-0512-5","article-title":"Developing therapeutic monoclonal antibodies at pandemic pace","volume":"38","author":"Kelley","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-024-00854-8","article-title":"FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines","volume":"9","author":"Macri","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-023-01030-0","article-title":"Fc-engineered monoclonal antibodies to reduce off-target liver uptake","volume":"13","author":"Mangeat","year":"2023","journal-title":"EJNMMI Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/mabs.20776","article-title":"Molecular engineering of antibodies for therapeutic and diagnostic purposes","volume":"4","author":"Ducancel","year":"2012","journal-title":"mAbs"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1158\/1078-0432.CCR-08-1474","article-title":"Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule","volume":"14","author":"Johnson","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/2326-6066.CIR-17-0661","article-title":"Nanobody\u2013Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses","volume":"6","author":"Woodham","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1039\/C7SC00446J","article-title":"Targeted antigen delivery by an anti-class II MHC VHH elicits focused \u03b1MUC1(Tn) immunity","volume":"8","author":"Fang","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1600692","article-title":"Generation of Immunity against Pathogens via Single-Domain Antibody\u2013Antigen Constructs","volume":"197","author":"Duarte","year":"2016","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41551-021-00738-5","article-title":"Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes","volume":"5","author":"Pishesha","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.4049\/jimmunol.1202592","article-title":"Targeting of autoantigens to DEC205(+) dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice","volume":"191","author":"Ring","year":"2013","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"980250","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: Principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e1147641","DOI":"10.1080\/2162402X.2016.1147641","article-title":"A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice","volume":"5","author":"Liu","year":"2016","journal-title":"OncoImmunology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Liu, Q., Liu, Y., Li, J., Huang, S., Chen, Z., Li, J., Wang, T., Zhou, P., Huo, J., and Li, D. (2026). A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control. Vaccines, 14.","DOI":"10.3390\/vaccines14030239"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Seretis, A., Amon, L., Tripp, C.H., Cappellano, G., Hornsteiner, F., Dieckmann, S., Vierthaler, J., Ortner-Tobider, D., Kanduth, M., and Steindl, R. (2025). Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma. Vaccines, 13.","DOI":"10.3390\/vaccines13040346"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1073\/pnas.1214994110","article-title":"Sortase-mediated modification of \u03b1DEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes","volume":"110","author":"Swee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cohn, L., and Delamarre, L. (2014). Dendritic Cell-Targeted Vaccines. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00255"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2250340","DOI":"10.1002\/eji.202250340","article-title":"Antibodies internalization mechanisms by dendritic cells and their role in therapeutic antibody immunogenicity","volume":"54","author":"Lteif","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molimm.2016.12.010","article-title":"Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes","volume":"81","author":"Macri","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-immunol-041015-055254","article-title":"The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules","volume":"35","author":"Cruz","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic Cells As Inducers of Peripheral Tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases","volume":"42","author":"Fondelli","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.2100932","article-title":"Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State","volume":"208","author":"Bourque","year":"2022","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bourque, J., and Hawiger, D. (2019). The BTLA\u2013HVEM\u2013CD5 Immunoregulatory Axis\u2013An Instructive Mechanism Governing pTreg Cell Differentiation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01163"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"108424","DOI":"10.1016\/j.celrep.2020.108424","article-title":"A Two-Step Process of Effector Programming Governs CD4(+) T Cell Fate Determination Induced by Antigenic Activation in the Steady State","volume":"33","author":"Opejin","year":"2020","journal-title":"Cell Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bourque, J., and Hawiger, D. (2023). Activation, Amplification, and Ablation as Dynamic Mechanisms of Dendritic Cell Maturation. Biology, 12.","DOI":"10.3390\/biology12050716"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20052005","article-title":"Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine","volume":"203","author":"Trumpfheller","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mi.2015.133","article-title":"A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract","volume":"9","author":"Ruane","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102845","DOI":"10.1016\/j.eclinm.2024.102845","article-title":"Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: A first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)","volume":"77","author":"Levy","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e01596-16","DOI":"10.1128\/JVI.01596-16","article-title":"Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses","volume":"91","author":"Zurawski","year":"2017","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/s41467-021-25382-0","article-title":"Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques","volume":"12","author":"Marlin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Flamar, A.-L., Bonnabau, H., Zurawski, S., Lacabaratz, C., Montes, M., Richert, L., Wiedemann, A., Galmin, L., Weiss, D., and Cristillo, A. (2018). HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207794"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.7150\/ijbs.57038","article-title":"Antigen Delivery to DEC205(+) Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites","volume":"17","author":"Silva","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Torres, D., K\u00f6hler, A., Delbauve, S., Caminschi, I., Lahoud, M.H., Shortman, K., and Flamand, V. (2016). IL-12p40\/IL-10 Producing preCD8\u03b1\/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005561"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-020-00810-3","article-title":"Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells","volume":"22","author":"Baharom","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Yizhak","year":"2018","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"111138","DOI":"10.1016\/j.celrep.2022.111138","article-title":"The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses","volume":"40","author":"Jung","year":"2022","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e20241148","DOI":"10.1084\/jem.20241148","article-title":"Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection","volume":"222","author":"Broomfield","year":"2025","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eadf4726","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: How dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.1901121","article-title":"Natural and Induced Tolerogenic Dendritic Cells","volume":"204","author":"Iberg","year":"2020","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","article-title":"Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance","volume":"987","author":"Steinman","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8(+) T Cell Tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41541-025-01084-2","article-title":"Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials","volume":"10","author":"Hussain","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2012.03.009","article-title":"The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments","volume":"36","author":"Zhang","year":"2012","journal-title":"Immunity"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1172\/JCI34584","article-title":"Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin","volume":"118","author":"Sancho","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2008-05-155176","article-title":"The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement","volume":"112","author":"Caminschi","year":"2008","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2011.10.007","article-title":"Boosting antibody responses by targeting antigens to dendritic cells","volume":"33","author":"Caminschi","year":"2012","journal-title":"Trends Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/eji.201344076","article-title":"Targeting DNGR-1 (CLEC9A) with antibody\/MUC1 peptide conjugates as a vaccine for carcinomas","volume":"44","author":"Picco","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.1101176","article-title":"Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype","volume":"187","author":"Lahoud","year":"2011","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4049\/jimmunol.1102541","article-title":"Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein","volume":"188","author":"Hemmi","year":"2012","journal-title":"J. Immunol."},{"key":"ref_98","first-page":"844","article-title":"Specialized role of migratory dendritic cells in peripheral tolerance induction","volume":"123","author":"Idoyaga","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.4049\/jimmunol.180.6.3647","article-title":"Cutting edge: Langerin\/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo","volume":"180","author":"Idoyaga","year":"2008","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/eji.202149670","article-title":"Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin","volume":"52","author":"Bellmann","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"106269","DOI":"10.1016\/j.ebiom.2026.106269","article-title":"Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses","volume":"127","author":"Hammoudi","year":"2026","journal-title":"eBioMedicine"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2337\/db14-1880","article-title":"DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes","volume":"64","author":"Price","year":"2015","journal-title":"Diabetes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.4049\/jimmunol.1300975","article-title":"Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice in vivo","volume":"192","author":"Neubert","year":"2014","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/eji.201040511","article-title":"Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague","volume":"40","author":"Do","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.crimmu.2021.08.001","article-title":"STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells","volume":"2","author":"Sulczewski","year":"2021","journal-title":"Curr. Res. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.1102307","article-title":"Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity","volume":"187","author":"Loschko","year":"2011","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.1303259","article-title":"Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance","volume":"192","author":"Chappell","year":"2014","journal-title":"J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.4049\/jimmunol.1004029","article-title":"Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity","volume":"186","author":"Loschko","year":"2011","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/eji.201242799","article-title":"Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation","volume":"43","author":"Moffat","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.immuni.2016.10.008","article-title":"Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells","volume":"45","author":"Jones","year":"2016","journal-title":"Immunity"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/eji.200838302","article-title":"CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses","volume":"38","author":"Castro","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/QAD.0b013e3283624305","article-title":"Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells","volume":"27","author":"Flamar","year":"2013","journal-title":"AIDS"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-16-0128","article-title":"Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity","volume":"4","author":"Yin","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"104062","DOI":"10.1016\/j.ebiom.2022.104062","article-title":"Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine","volume":"80","author":"Wiedemann","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/CJI.0b013e318135472c","article-title":"In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models","volume":"30","author":"Qin","year":"2007","journal-title":"J. Immunother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2011-04-346957","article-title":"Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation","volume":"118","author":"Tacken","year":"2011","journal-title":"Blood"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/eji.201343429","article-title":"In vivo targeting of human DC-SIGN drastically enhances CD8+ T-cell-mediated protective immunity","volume":"43","author":"Hesse","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.1000808","article-title":"Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity","volume":"186","author":"Tsuji","year":"2011","journal-title":"J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI34224","article-title":"The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells","volume":"118","author":"Nchinda","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Cao, J., Jin, Y., Li, W., Zhang, B., He, Y., Liu, H., Xia, N., Wei, H., and Yan, J. (2013). DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice. BMC Immunol., 14.","DOI":"10.1186\/1471-2172-14-39"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.imlet.2017.08.004","article-title":"Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells","volume":"190","author":"Chen","year":"2017","journal-title":"Immunol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Zaneti, A.B., Yamamoto, M.M., Sulczewski, F.B., Almeida, B.d.S., Souza, H.F.S., Ferreira, N.S., Maeda, D.L.N.F., Sales, N.S., Rosa, D.S., and Ferreira, L.C.d.S. (2019). Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4+ T Cells to the Dengue Virus Envelope Protein Domain III. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00059"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.imlet.2015.10.007","article-title":"A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice","volume":"168","author":"Yu","year":"2015","journal-title":"Immunol. Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/imm.12467","article-title":"DNA vaccines encoding DEC205-targeted antigens: Immunity or tolerance?","volume":"145","author":"Niezold","year":"2015","journal-title":"Immunology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"110140","DOI":"10.1016\/j.intimp.2023.110140","article-title":"Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody","volume":"119","author":"Cheng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2304818","DOI":"10.1002\/advs.202304818","article-title":"Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2","volume":"10","author":"Albericio","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_128","first-page":"13","article-title":"Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics","volume":"6","author":"Zhang","year":"2023","journal-title":"Antib. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/19420862.2018.1553476","article-title":"Structure, heterogeneity and developability assessment of therapeutic antibodies","volume":"11","author":"Xu","year":"2019","journal-title":"mAbs"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1743053","DOI":"10.1080\/19420862.2020.1743053","article-title":"Predicting Antibody Developability Profiles Through Early Stage Discovery Screening","volume":"12","author":"Bailly","year":"2020","journal-title":"mAbs"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2394229","DOI":"10.1080\/19420862.2024.2394229","article-title":"Developability considerations for bispecific and multispecific antibodies","volume":"16","author":"Amash","year":"2024","journal-title":"mAbs"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchromb.2006.09.026","article-title":"Downstream processing of monoclonal antibodies\u2014Application of platform approaches","volume":"848","author":"Shukla","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Fallahee, I., and Hawiger, D. (2024). Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies. Antibodies, 13.","DOI":"10.1101\/2024.01.03.574076"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20121251","article-title":"Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation","volume":"210","author":"Cohn","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood-2010-06-288068","article-title":"Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody","volume":"116","author":"Cheong","year":"2010","journal-title":"Blood"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0610383104","article-title":"DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes","volume":"104","author":"Bozzacco","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41541-025-01214-w","article-title":"Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination","volume":"10","author":"Lanza","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-03-148072","article-title":"Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses","volume":"112","author":"Gurer","year":"2008","journal-title":"Blood"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI125364","article-title":"Heterologous prime-boost vaccination protects against EBV antigen\u2013expressing lymphomas","volume":"129","author":"Citterio","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ahmed, E.H., Brooks, E., Sloan, S., Schlotter, S., Jeney, F., Hale, C., Mao, C., Zhang, X., McLaughlin, E., and Shindiapina, P. (2021). Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease. Vaccines, 9.","DOI":"10.3390\/vaccines9060555"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Wang, W.-C., Sayedahmed, E.E., Sambhara, S., and Mittal, S.K. (2022). Progress towards the Development of a Universal Influenza Vaccine. Viruses, 14.","DOI":"10.3390\/v14081684"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.vaccine.2019.02.050","article-title":"Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Shrestha, A., Sadeyen, J.-R., Lukosaityte, D., Chang, P., Van Hulten, M., and Iqbal, M. (2021). Targeting Haemagglutinin Antigen of Avian Influenza Virus to Chicken Immune Cell Receptors Dec205 and CD11c Induces Differential Immune-Potentiating Responses. Vaccines, 9.","DOI":"10.3390\/vaccines9070784"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/mi.2014.133","article-title":"Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection","volume":"8","author":"Wakim","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1093\/infdis\/jiae613","article-title":"Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease","volume":"231","author":"Olal","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-026-01426-8","article-title":"The current landscape of therapeutic vaccination approaches for treatment of HPV-dependent malignancies","volume":"11","author":"Schlosser","year":"2026","journal-title":"npj Vaccines"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Pal, A., and Kundu, R. (2020). Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.03116"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1016\/j.vaccine.2012.08.051","article-title":"Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205\/CD205 receptor","volume":"30","author":"Do","year":"2012","journal-title":"Vaccine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.vaccine.2011.01.030","article-title":"Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice","volume":"29","author":"Stylianou","year":"2011","journal-title":"Vaccine"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Velasquez, L.N., St\u00fcve, P., Gentilini, M.V., Swallow, M., Bartel, J., Lycke, N.Y., Barkan, D., Martina, M., Lujan, H.D., and Kalay, H. (2018). Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00471"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mi.2012.92","article-title":"Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells","volume":"6","author":"Dong","year":"2013","journal-title":"Mucosal Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Silva-S\u00e1nchez, A., Meza-P\u00e9rez, S., Flores-Langarica, A., Donis-Maturano, L., Estrada-Garc\u00eda, I., Calder\u00f3n-Amador, J., Hern\u00e1ndez-Pando, R., Idoyaga, J., Steinman, R.M., and Flores-Romo, L. (2015). ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124828"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"128753","DOI":"10.1016\/j.vaccine.2026.128753","article-title":"Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis","volume":"86","author":"Counoupas","year":"2026","journal-title":"Vaccine"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Matos, I., Mizenina, O., Lubkin, A., Steinman, R.M., and Idoyaga, J. (2013). Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity. PLoS ONE, 8.","DOI":"10.1371\/annotation\/5149bf8e-3843-4865-a726-0ca2820ee8f8"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Lakhrif, Z., Moreau, A., H\u00e9rault, B., Di-Tommaso, A., Juste, M., Moir\u00e9, N., Dimier-Poisson, I., M\u00e9v\u00e9lec, M.N., and Aubrey, N. (2018). Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00317"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/08820139.2022.2109486","article-title":"Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities","volume":"51","author":"Fu","year":"2022","journal-title":"Immunol. Investig."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Hossain, M.K., and Wall, K.A. (2019). Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses. Cancers, 11.","DOI":"10.3390\/cancers11030418"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1158\/0008-5472.CAN-05-0938","article-title":"Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice","volume":"65","author":"Mahnke","year":"2005","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr3135","article-title":"Targeting of the non-mutated tumor antigen HER2\/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice","volume":"14","author":"Wang","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-020-00143-y","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"100106","DOI":"10.1016\/j.bneo.2025.100106","article-title":"Checkpoint immunotherapy is associated with preferential activation of tumor antigen\u2013specific CD4+ T cells in MDS","volume":"2","author":"Griffiths","year":"2025","journal-title":"Blood Neoplasia"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.omto.2020.10.007","article-title":"Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy","volume":"19","author":"Tzelepis","year":"2020","journal-title":"Mol. Ther.\u2014Oncolytics"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"102520","DOI":"10.1016\/j.omtn.2025.102520","article-title":"Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers","volume":"36","author":"Dietmair","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/acsnano.5c20535","article-title":"Dual-Targeting mRNA Cancer Vaccines for Simultaneous Antigen Presentation in Dendritic and Tumor Cells","volume":"20","author":"Kim","year":"2026","journal-title":"ACS Nano"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.4049\/jimmunol.169.9.5322","article-title":"Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors","volume":"169","author":"Tillman","year":"2002","journal-title":"J. Immunol."},{"key":"ref_169","first-page":"5456","article-title":"Adenoviral Vectors Targeted to CD40 Enhance the Efficacy of Dendritic Cell-based Vaccination against Human Papillomavirus 16-induced Tumor Cells in a Murine Model","volume":"60","author":"Tillman","year":"2000","journal-title":"Cancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s13311-018-0650-3","article-title":"A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model","volume":"15","author":"Kim","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41417-017-0002-1","article-title":"Development of an adenovirus vector vaccine platform for targeting dendritic cells","volume":"25","author":"Sharma","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/acschembio.5c00318","article-title":"Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells","volume":"20","author":"Yamazoe","year":"2025","journal-title":"ACS Chem. Biol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/788\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:51:56Z","timestamp":1788947516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":172,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090788"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090788","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}